[HTML][HTML] Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
PJ Wiechno, J Bellmunt, C Lucas, WC Su, L Albiges… - Annals of …, 2016 - Elsevier
Background There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
[PDF][PDF] Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2016 - pdfs.semanticscholar.org
Background: There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, P Wiechno, J Bellmunt, C Lucas… - ANNALS OF …, 2016 - iris.unisr.it
There is no standard first-line chemotherapy for advanced urothelial carcinoma (aUC) in
cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and tolerability …
cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and tolerability …
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt, C Lucas, WC Su… - 2016 - mediatum.ub.tum.de
There is no standard first-line chemotherapy for advanced urothelial carcinoma (aUC) in
cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and tolerability …
cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and tolerability …
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of Oncology …, 2015 - europepmc.org
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit
patients with advanced urothelial carcinoma: results of an international randomized phase II …
patients with advanced urothelial carcinoma: results of an international randomized phase II …
Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2016 - annalsofoncology.org
Background There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
[PDF][PDF] Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2016 - ppm-system.gumed.edu.pl
Background: There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
[PDF][PDF] Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2016 - ppm.gumed.edu.pl
Background: There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2016 - researchoutput.ncku.edu.tw
Background: There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …
M De Santis, PJ Wiechno, J Bellmunt… - Annals of …, 2015 - wrap.warwick.ac.uk
Background: There is no standard first-line chemotherapy for advanced urothelial carcinoma
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …
(aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and …